Business This genome modifying inventory may surge greater than 60%, JPMorgan says – KhabarSahiHaiBy adminJanuary 30, 20240 Business JPMorgan thinks buyers ought to flock to biotechnology firm Beam Therapeutics , which the agency says stands to learn from…